CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research investigates the use of Genipin, a natural cross-linking agent, for treating keratoconus and related corneal inflammatory diseases. It aims to establish a new therapeutic approach that avoids the complications of traditional treatments.
Keratoconus is an eye disorder in which the normally curved cornea, the clear window of the eye, progressively thins and begins to bulge into a cone-like shape, leading to significant visual impairment.
Corneal cross-linking is the gold standard treatment for halting disease progression by using riboflavin activated by ultraviolet light (UVA) to introduce covalent chemical bonds (cross-links) into the cornea.
To enhance permeability of riboflavin into the corneal stroma, epithelium removal is re…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Colombia, Bogota
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
